Abstract

Sickle cell disease is the commonest haemoglobinopathy within the United Kingdom.1 Although the majority of patients will present to hospitals within major cities, this is not invariably the case. It is therefore important that all physicians on acute medical take are familiar with the acute management of sickle cell disease. This review encompasses the initial management which is subdivided into analgesia, investigations and supportive care. In addition the more severe complications of sickle cell, including the acute chest syndrome and stroke are covered. It should be remembered that close collaboration is required with the haematology department, particularly in those patients with respiratory distress or stroke, so that prompt arrangements can be made if exchange transfusion is required.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. Hickman M, Modell B, Greengross P, et al. Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates. Br J Haem 1999; 104: 860-867.
2. Serjeant GR. Sickle-cell disease. Lancet 1997; 350: 725-730.
3. Rees DC, Olujohengbe AD, Parker NE, et al. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haem 2003; 120: 744-752.
4. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. NEJM 1994; 330: 1639- 1644.
5. Pegelow CH.; Survey of pain management therapy provided for children with sickle cell disease. Clin Pediatrics 1992; 31: 211-214.
6. Serjeant BE, Hambleton IR, Kerr S, et al. Haematological response to parvovirus B19 infection in homozygous sickle cell disease. Lancet 2001; 358: 1779-1780.
7. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunisation in sickle cell anaemia and transfusion of racially unmatched blood. NEJM 1990; 322: 1617-1621.
8. Burnett MW, Bass JW & Cook BA; Etiology of osteomyelitis complicating sickle cell disease. Pediatrics 1998; 101: 296-297.
9. Mehta P, Bareford D, Wright C, et al. High complication rate of central lines in SCD. Br J Haem 2002; 117: 9a.
10. Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989; 84: 500-508.
11. Falletta JM, Woods GM, Verter JI, et al. Discontinuing penicillin prophylaxis in children with sickle cell anaemia. Prophylactic Penicillin Study II. J Pediatr 1995; 127: 685-690.
12. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood 1997; 89: 1787- 1792.
13. Wright JG, Malia R, Cooper P, et al. Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels? Br J Haem 1997; 98: 627-631.
14. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in Sickle Cell Disease. Blood 1994; 84: 643-649.
15. Emre U, Miller ST, Gutierez M, et al. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatrics 1995; 127: 901-904.
16. Bellet PS, Kalinyak KA, Shukla R, et al. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. NEJM 1995; 333(11):699-703.
17. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular disease in sickle cell disease: rates and risk factors. Blood 1998; 91: 288-294.
18. Powers D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med 1978; 65: 461-471.
19. Vichinsky EP; New therapies in sickle cell disease. Lancet 2002; 360: 629- 631.
20. Okpala I, Westerdale N, Jegede T, et al. Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Haematol 2002; 118: 918-921.